Squamous Cell Carcinoma of Unknown Primary Clinical Trials in Ann Arbor, Michigan

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment